Bill > SB14

This bill creates new protections for 340B covered entities (healthcare facilities registered under a specific federal program) in their interactions with pharmaceutical manufacturers. The legislation defines key terms like "340B price" and "covered drug" based on federal standards and prohibits manufacturers from discriminating against these entities by refusing or limiting 340B pricing for drugs. Specifically, if a manufacturer offers a drug at the 340B price in any other state, they cannot deny or restrict that same pricing in Kentucky. The bill allows any person who believes a manufacturer is violating these provisions to file a complaint with the Attorney General, who can then investigate the matter under existing state law. The legislation includes language ensuring that these new protections do not conflict with or reduce the standards of existing federal or state laws. Importantly, the bill aims to prevent pharmaceutical manufacturers from creating barriers that would make it more difficult for certain healthcare facilities to access discounted drug pricing, thereby potentially improving medication affordability and access for patients served by 340B covered entities.

Health and Social Services

https://apps.legislature.ky.gov/record/25RS/sb14.html